ROLE OF COX-2/MPGES-1 AXIS ON VASCULAR REMODELING IN HYPERTENSION

被引:0
|
作者
Avendano, M. S. [1 ]
Martinez-Revelles, S. [1 ]
Aguado, A. [1 ]
Simoes, M. R. [1 ,5 ]
Aras-Lopez, R. [1 ]
Iniguez, M. A. [2 ,3 ]
Cachofeiro, M., V [4 ]
Vila, L. [6 ]
Camacho, M. [6 ]
Salaices, M. [1 ]
Briones, A. M. [1 ]
机构
[1] Univ La Paz IdiPAZ, Inst Invest Hosp, Univ Autonoma Madrid, Fac Med, Madrid, Spain
[2] Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, E-28049 Madrid, Spain
[3] CSIC, Madrid, Spain
[4] Univ Complutense, Fac Med, E-28040 Madrid, Spain
[5] Univ Fed Espirito Santo, Vitoria, ES, Brazil
[6] Hosp Santa Creu & Sant Pau, Barcelona, Spain
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
12
引用
收藏
页码:29 / 29
页数:1
相关论文
共 50 条
  • [31] EFFECT OF ANGIOTENSIN II ON INTERLEUKYN-1BETA INDUCED COX-2 AND MPGES-1 EXPRESSION IN PERIVASCULAR FIBROBLASTS
    Galan, M.
    Miguel, M.
    Beltran, A.
    Rodriguez, C.
    Alonso, M. J.
    Martinez-Gonzalez, J.
    Salaices, M.
    JOURNAL OF HYPERTENSION, 2010, 28 : E492 - E492
  • [32] Preferential coupling between cox-2 and mPGES-1 in murine endothelial cell line SVEC4-10
    Elharrrar, V
    Konger, RL
    Franklin, K
    Corthals, SM
    Klaunig, JE
    FASEB JOURNAL, 2006, 20 (04): : A228 - A228
  • [33] Roles of PGE2 produced via the COX-2 and mPGES-1 pathway in abscess of zymosan-induced pleurisy
    Kawamura, Michiko
    Inada, Toshihisa
    Hatanaka, Ko
    Harada, Yoshiteru
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2008, 106 : 148P - 148P
  • [34] Inhibition of mPGES-1 or COX-2 Results in Different Proteomic and Lipidomic Profiles in A549 Lung Cancer Cells
    Bergqvist, Filip
    Ossipova, Elena
    Idborg, Helena
    Raouf, Joan
    Checa, Antonio
    Englund, Karin
    Englund, Petter
    Khoonsari, Payam Emami
    Kultima, Kim
    Wheelock, Craig E.
    Larsson, Karin
    Korotkova, Marina
    Jakobsson, Per-Johan
    FRONTIERS IN PHARMACOLOGY, 2019, 10
  • [35] GSK-3 inhibitors suppress the expression of COX-2 and mPGES-1 by the reduction of intranuclear NF-κB
    Noma, Toshihiro
    Takahashi, Fumi
    Arioka, Masaki
    Sasaguri, Toshiyuki
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2015, 128 (03) : S216 - S216
  • [36] COX-2 but Not mPGES-1 Contributes to Renal PGE2 Induction and Diabetic Proteinuria in Mice with Type-1 Diabetes
    Jia, Zhanjun
    Sun, Ying
    Liu, Shanshan
    Liu, Ying
    Yang, Tianxin
    PLOS ONE, 2014, 9 (07):
  • [37] Prostaglandin E2 produced by inducible COX-2 and mPGES-1 promoting cancer cell proliferation in vitro and in vivo
    Ruan, Diana
    So, Shui-Ping
    LIFE SCIENCES, 2014, 116 (01) : 43 - 50
  • [38] Up-regulation of COX-2 and mPGES-1 by 27-hydroxycholesterol and 4-hydroxynonenal: A crucial role in atherosclerotic plaque instability
    Gargiulo, Simona
    Rossin, Daniela
    Testa, Gabriella
    Gamba, Paola
    Staurenghi, Erica
    Biasi, Fiorella
    Poli, Giuseppe
    Leonarduzzi, Gabriella
    FREE RADICAL BIOLOGY AND MEDICINE, 2018, 129 : 354 - 363
  • [39] Diosgenin suppresses COX-2 and mPGES-1 via GR and improves LPS-induced liver injury in mouse
    Tsukayama, Izumi
    Mega, Takuto
    Hojo, Nana
    Toda, Keisuke
    Kawakami, Yuki
    Takahashi, Yoshitaka
    Suzuki-Yamamoto, Toshiko
    PROSTAGLANDINS & OTHER LIPID MEDIATORS, 2021, 156
  • [40] 前列腺癌组织mPGES-1表达及其与COX-2的相关性
    尚芳芳
    于小玲
    齐瑞芳
    李玉芝
    姜长青
    齐鲁医学杂志, 2008, (03) : 201 - 203